Dr Michael Down BSc PhD appointed to Board of Genwat Services Limited
Dr Michael Down BSc PhD appointed to Board of Genwat Services Limited 6th July 2009
Dr Michael Down has been appointed as a non executive Director of Genwat.
Mark Mills, Chairman of Genwat commented “Dr Michael Down’s appointment to Genwat underlines the credibility of Genwat’s business and aspirations.
Michael is an industry wide respected figure whose achievements have been admired across Europe. We are delighted to have him on board and look forward to working with him and benefitting from his technical expertise”
Dr Down added “NM Rothschild and Sons introduced me to Mark Mills and the Genwat business model and I am excited to be involved in such a progressive project”
Dr Michael Down has been appointed as a non executive Director of Genwat.
Mark Mills, Chairman of Genwat commented “Dr Michael Down’s appointment to Genwat underlines the credibility of Genwat’s business and aspirations.
Michael is an industry wide respected figure whose achievements have been admired across Europe. We are delighted to have him on board and look forward to working with him and benefitting from his technical expertise”
Dr Down added “NM Rothschild and Sons introduced me to Mark Mills and the Genwat business model and I am excited to be involved in such a progressive project”
Michael has 30 years experience in nuclear and engineering industries with American (Westinghouse), UK (GEC/NNC), German (RWE) and French (Vinci) owned companies.
Michael took ailing 45-man UK subsidiary of RWE NUKEM to full recovery then identified and led acquisitions and divestments resulting in its sale as a €200 million business.
Career Highlights
• Consistently successful and respected in a varied career at senior level - academic research, US multinational, GEC-owned nuclear reactor construction, German utility-owned nuclear engineering business and French-owned civil construction group.
• Built NUKEM Limited from 45 people to over 1000 during 13 years as Chief Executive
• Identified and personally drove through the acquisition of AEA Technology’s nuclear engineering business (700 people) in 2001. Then led the integration of this former-UKAEA business into the private sector, including all issues of TUPE, government pensions, union recognition etc.
• Joint Managing Director with two German colleagues to lead the sale of the NUKEM Group to the Advent private equity company in 2006. Worked closely with UBS who managed the sale process.
• Took an equity stake in the business and then played a leading role in the strategy to split the NUKEM Group and proceed on a “fast exit” from private equity ownership.
• Led the sale of NUKEM Limited to Freyssinet for a multiplier in excess of 20 x EBITDA. Wrote the Information Memorandum, designed and led the management presentations, worked with NM Rothschild to conduct all aspects of the sale including bid lists, short-listing, due diligence, sale and purchase agreements, etc.
• Led the Company through a number of brand and cultural changes including the most recent integration into the international Vinci Group and formation of the Nuvia brand.
Michael took ailing 45-man UK subsidiary of RWE NUKEM to full recovery then identified and led acquisitions and divestments resulting in its sale as a €200 million business.
Career Highlights
• Consistently successful and respected in a varied career at senior level - academic research, US multinational, GEC-owned nuclear reactor construction, German utility-owned nuclear engineering business and French-owned civil construction group.
• Built NUKEM Limited from 45 people to over 1000 during 13 years as Chief Executive
• Identified and personally drove through the acquisition of AEA Technology’s nuclear engineering business (700 people) in 2001. Then led the integration of this former-UKAEA business into the private sector, including all issues of TUPE, government pensions, union recognition etc.
• Joint Managing Director with two German colleagues to lead the sale of the NUKEM Group to the Advent private equity company in 2006. Worked closely with UBS who managed the sale process.
• Took an equity stake in the business and then played a leading role in the strategy to split the NUKEM Group and proceed on a “fast exit” from private equity ownership.
• Led the sale of NUKEM Limited to Freyssinet for a multiplier in excess of 20 x EBITDA. Wrote the Information Memorandum, designed and led the management presentations, worked with NM Rothschild to conduct all aspects of the sale including bid lists, short-listing, due diligence, sale and purchase agreements, etc.
• Led the Company through a number of brand and cultural changes including the most recent integration into the international Vinci Group and formation of the Nuvia brand.
